Natalie Morton, of Coventry in the United Kingdom, died on 30th Sept 2009, the day she received the HPV vaccine. She collapsed less than 2 hours after the injection, which was the first dose of a planned 3-dose course.
Another 14-year-old British girl died shortly after she received Cervarix, a vaccine against human papillomavirus (HPV) also on Sept 30th 2009. The death is being reported as unlikely to have been related to the vaccine. The next day, a postmortem revealed that the girl had a large tumor in her chest cavity.
Several health authorities in the United Kingdom announced that they were temporarily suspending their HPV vaccination programs.
Cervarix is used for 2 types of HPV virus (types 16 and 18), which together account for about 70% of all cervical cancer. Gardasil in addition to type 16 and 18 also is used for types 6 and 11, which cause genital warts.
The August 19 issue of JAMA also published details of adverse events that have been reported with Gardasil during its 2.5 years on the market (JAMA. 2009;302:750-757). These reports were made to the US Vaccine Adverse Event Reporting System, which is operated jointly by the FDA and the Centers for Disease Control and Prevention (CDC). The authors emphasized that a report of an adverse event does not necessarily mean there is a causal link. The paper noted that 12,424 reports of adverse events had been received, of which 772 (6.2%) were for serious adverse events, including 32 deaths. For the full details go to http://www.medscape.com/viewarticle/709718?sssdmh=dm1.537034&src=nldne&uac=137750MN
Consider the health of your teenagers before you vaccinate.
Jenni Beasley Naturopath, Neuro-Trainer, Kinesiologist
Comments